SPATA9 inhibitors are a class of chemical compounds specifically designed to target and modulate the activity of the SPATA9 protein, a member of the spermatogenesis-associated family of proteins. SPATA9, also known as Spermatogenesis Associated 9, is primarily involved in cellular processes related to spermatogenesis, but it also plays roles in other biological processes. The inhibitors of SPATA9 function by binding to specific sites on the protein, thereby disrupting its normal interactions and activities within the cell. The design of these inhibitors often involves detailed structural analysis of SPATA9 to identify key binding pockets or domains that are crucial for its function. By targeting these specific sites, SPATA9 inhibitors can effectively alter the protein's conformation, leading to a reduction or complete inhibition of its activity.
The development of SPATA9 inhibitors involves a combination of computational modeling, high-throughput screening, and biochemical assays to identify and optimize compounds that exhibit high specificity and potency. Structural biology techniques, such as X-ray crystallography or cryo-electron microscopy, are frequently used to obtain high-resolution images of the SPATA9 protein, providing essential information about its active sites and potential allosteric sites where inhibitors could bind. Once potential inhibitors are identified, they are subjected to rigorous testing to assess their binding affinity, selectivity, and ability to modulate SPATA9 activity in vitro. These studies help in refining the chemical structure of the inhibitors to enhance their effectiveness. Additionally, the interactions of SPATA9 inhibitors with other cellular proteins and pathways are carefully examined to understand their broader impact on cellular functions. The goal of these efforts is to create highly selective SPATA9 inhibitors that can provide insights into the biological role of SPATA9 in various cellular contexts and contribute to the broader understanding of protein function within the spermatogenesis-associated family.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
As a glycolysis inhibitor, 2-Deoxy-D-glucose could indirectly affect energy metabolism, potentially impacting spermatogenesis and SPATA9 activity. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid, all trans is crucial in spermatogenesis. Altering retinoic acid signaling might indirectly influence SPATA9's role in sperm development. | ||||||
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
A histone deacetylase inhibitor, Trichostatin A can alter chromatin structure and gene expression, potentially affecting SPATA9 expression. | ||||||
5-Azacytidine | 320-67-2 | sc-221003 | 500 mg | $280.00 | 4 | |
This DNA methyltransferase inhibitor can lead to changes in gene expression, which might indirectly affect SPATA9. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein, a tyrosine kinase inhibitor, might influence signaling pathways associated with spermatogenesis and potentially impact SPATA9. | ||||||
Cyclophosphamide | 50-18-0 | sc-361165 sc-361165A sc-361165B sc-361165C | 50 mg 100 mg 500 mg 1 g | $90.00 $146.00 $469.00 $791.00 | 18 | |
Cyclophosphamide, an alkylating agent, affects rapidly dividing cells and could indirectly influence spermatogenic processes involving SPATA9. | ||||||
Busulfan | 55-98-1 | sc-204658 | 10 g | $49.00 | 3 | |
Busulfan, an alkylating agent, can impact spermatogenesis, potentially affecting SPATA9's role. | ||||||
Nocodazole | 31430-18-9 | sc-3518B sc-3518 sc-3518C sc-3518A | 5 mg 10 mg 25 mg 50 mg | $59.00 $85.00 $143.00 $247.00 | 38 | |
As a microtubule disruptor, Nocodazole can affect cell division and might indirectly influence SPATA9 activity during spermatogenesis. | ||||||
Taxol | 33069-62-4 | sc-201439D sc-201439 sc-201439A sc-201439E sc-201439B sc-201439C | 1 mg 5 mg 25 mg 100 mg 250 mg 1 g | $41.00 $74.00 $221.00 $247.00 $738.00 $1220.00 | 39 | |
Taxol stabilizes microtubules and could impact cell division processes relevant to SPATA9's function in spermatogenesis. | ||||||
Vinblastine | 865-21-4 | sc-491749 sc-491749A sc-491749B sc-491749C sc-491749D | 10 mg 50 mg 100 mg 500 mg 1 g | $102.00 $235.00 $459.00 $1749.00 $2958.00 | 4 | |
This microtubule-disrupting agent might indirectly affect SPATA9 by altering cell division processes in spermatogenesis. | ||||||